Amphora® completed a phase III contraceptive clinical trial.

Read More


Amphora® offers potential applications for women all over the world.

Read More


Evofem is committed
to giving women access to better healthcare options.

Read More

Empower Women logo_vChange the World

Evofem develops and markets products that are woman-controlled, non-invasive and rapidly reversible. Women need access to effective products that are well suited to their lifestyle and consistent with their core values.

Latest News


Evofem Holdings, Inc. Announces Successful Completion of Pre-IND Meeting for Amphora®

January 11, 2016

SAN DIEGO – Evofem, a biotechnology company focused on the development and commercialization of women’s health products, announced today that it met with representatives of the U.S. Food and Drug Administration (“FDA”) in a Pre-IND (Investigational New Drug) meeting for its lead product, Amphora to be evaluated for the prevention of recurrence of Bacterial Vaginosis…

More News